OAinject: Fighting osteoarthritis
In the Netherlands, more than 1.5 million people suffer from osteoarthritis – a chronic degenerative rheumatic condition of the joints that causes pain, stiffness and restriction in daily moving. As osteoarthritis is a condition that mainly occurs among older people, the number of patients is set to greatly increase due to the ageing of Dutch society. At present, there is no adequate treatment for osteoarthritis.
Maastricht University is part of the OAinject consortium, funded by the Perspectief program of the Dutch Research Council (NWO), that will develop new diagnostic tools to determine which form of osteoarthritis a patient has. This way more accurate individualised treatments can be offered in the future. The researchers will also work on innovative ways of gradually administering drugs locally over a extended period of time via an injectable drug depot in the diseased joint. With this approach, the consortium aims to develop novel methods that are expected to support a durable active lifestyle for osteoarthritis patients.
Our CAPHRI/ MUMC+ researchers Tim Welting and Pieter Emans from the Department of Orthopedic Surgery are co-initiator and member of the OAinject project. The project is led by Marcel Karperien of the University of Twente.
Consortium
Programme leader: Prof. Marcel Karperien (University of Twente)
Participating knowledge institutions: Delft University of Technology, Erasmus MC, Maastricht University, Maastricht University Medical Center, Radboud university medical center, University Medical Center Utrecht, University of Twente
Companies: Chondropeptix, DSM Biomedical, IBIS Technologies, InnoCore Pharmaceuticals, 20Med Therapeutics, Nordic Bioscience, Orthros Medical, Procore, QVQ, Ssens
Other societal partners: Deventer Hospital, ReumaNederland, Dutch Society for the Replacement of Animal Testing
Prof. dr. Tim Welting, PhD
Professor of Molecular Cartilage Biology
Ad interim Chair of the Department of Orthopedic Surgery
Head of the Laboratory for Experimental Orthopedics
t.welting@maastrichtuniversity.nl
Video
Also read
-
The delayed diagnosis of endometriosis
In Honours+, students gain their first experience in approaching (global) challenges in an interdisciplinary setting, under the professional guidance of staff members from Maastricht University.
-
Creating an identity card with DNA
By looking at just a few letters in your genome, researchers can roughly tell your age, and if you are a smoker or stopped smoking. Athina Vidaki uses these genetic techniques to help solve sexual assault cases.
-
Standard treatment for stomach complaints is no more effective than a placebo
A drug often prescribed for chronic stomach complaints is no more effective than a placebo. What does matter, however, is whether patients believe they are receiving the medicine, according to research by Daniel Keszthelyi.
